<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, there is no specific and effective vaccine or therapy available for preventing or treating NoV gastroenteritis [
 <xref ref-type="bibr" rid="CR000834">34</xref>]. General clinical management includes oral administration of rehydration solutions containing essential electrolytes and sugar to treat diarrhea. Parenteral fluid and electrolyte replacement may be required for patients with significant dehydration symptoms or those who cannot tolerate oral fluids replacement [
 <xref ref-type="bibr" rid="CR00084">4</xref>]. Current efforts are focused on the development of effective vaccines and possible attachment inhibitors for anti-adhesion therapy through glycomimetics [
 <xref ref-type="bibr" rid="CR000891">91</xref>].
</p>
